Susquehanna International Group’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q1 | – | Sell |
-1,236,697
| Closed | -$141K | – | 5258 |
|
2018
Q4 | $141K | Sell |
1,236,697
-938,999
| -43% | -$107K | ﹤0.01% | 3088 |
|
2018
Q3 | $3.7M | Sell |
2,175,696
-253,974
| -10% | -$432K | ﹤0.01% | 679 |
|
2018
Q2 | $4.23M | Buy |
2,429,670
+506,295
| +26% | +$881K | ﹤0.01% | 664 |
|
2018
Q1 | $3.52M | Sell |
1,923,375
-12,388,785
| -87% | -$22.7M | ﹤0.01% | 648 |
|
2017
Q4 | $31.9M | Buy |
14,312,160
+11,782,938
| +466% | +$26.3M | 0.01% | 144 |
|
2017
Q3 | $7.34M | Buy |
2,529,222
+133,512
| +6% | +$387K | ﹤0.01% | 393 |
|
2017
Q2 | $10.7M | Sell |
2,395,710
-1,001,984
| -29% | -$4.46M | ﹤0.01% | 301 |
|
2017
Q1 | $15.8M | Buy |
3,397,694
+2,278,872
| +204% | +$10.6M | 0.01% | 189 |
|
2016
Q4 | $6.81M | Buy |
1,118,822
+766,468
| +218% | +$4.67M | ﹤0.01% | 422 |
|
2016
Q3 | $1.94M | Sell |
352,354
-116,794
| -25% | -$643K | ﹤0.01% | 953 |
|
2016
Q2 | $1.78M | Buy |
469,148
+256,110
| +120% | +$973K | ﹤0.01% | 1108 |
|
2016
Q1 | $588K | Sell |
213,038
-31,383
| -13% | -$86.6K | ﹤0.01% | 2521 |
|
2015
Q4 | $1.39M | Buy |
244,421
+372
| +0.2% | +$2.11K | ﹤0.01% | 1944 |
|
2015
Q3 | $1.29M | Buy |
244,049
+223,910
| +1,112% | +$1.19M | ﹤0.01% | 2112 |
|
2015
Q2 | $167K | Sell |
20,139
-219,899
| -92% | -$1.82M | ﹤0.01% | 4141 |
|
2015
Q1 | $1.11M | Buy |
240,038
+107,104
| +81% | +$495K | ﹤0.01% | 2330 |
|
2014
Q4 | $405K | Sell |
132,934
-145,788
| -52% | -$444K | ﹤0.01% | 3511 |
|
2014
Q3 | $776K | Buy |
278,722
+5,349
| +2% | +$14.9K | ﹤0.01% | 2593 |
|
2014
Q2 | $1.11M | Buy |
273,373
+50,794
| +23% | +$207K | ﹤0.01% | 2316 |
|
2014
Q1 | $1.18M | Buy |
222,579
+153,671
| +223% | +$816K | ﹤0.01% | 1948 |
|
2013
Q4 | $382K | Buy |
68,908
+41,169
| +148% | +$228K | ﹤0.01% | 3036 |
|
2013
Q3 | $125K | Sell |
27,739
-63,439
| -70% | -$286K | ﹤0.01% | 3263 |
|
2013
Q2 | $388K | Buy |
+91,178
| New | +$388K | ﹤0.01% | 2694 |
|